-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The oncological safety of transanorectal total mesangial resection (TaTME) for the treatment of rectal cancer has recently been questioned, and a high local recurrence rate (LR) has been reported in clinical practice in the Netherlands and Norway
The oncological safety of transanorectal total mesangial resection (TaTME) for the treatment of rectal cancer has recently been questioned, and a high local recurrence rate (LR) has been reported in clinical practice in the Netherlands and Norway
This is a prospective internationally registered cohort study, including all patients with primary rectal adenocarcinoma treated with TaTME from February 2010 to December 2018
This is a prospective internationally registered cohort study, including all patients with primary rectal adenocarcinoma treated with TaTME from February 2010 to December 2018
After a median follow-up of 24 months (IQR, 12-38 months), the 2-year LR rate was 4.
LR rate
Multivariate Cox regression analysis showed that the independent risk factor for LR was male (OR, 1.
Multivariate Cox regression analysis showed that the independent risk factor for LR was male (OR, 1.
LR related factors
The 2-year DFS rate was 76.
The 2-year DFS rate was 76.
DFS rate
The 2-year OS rate was 91.
The 2-year OS rate was 91.
OS rate
In summary, the study shows that the transanorectal total mesangectomy (TaTME) treatment of rectal cancer has an acceptable LR rate
In summary, the study shows that the transanorectal total mesangectomy (TaTME) treatment of rectal cancer has an acceptable LR rate
.
This study shows that the transanorectal total mesangectomy (TaTME) treatment of rectal cancer has an acceptable LR rate
.
This study shows that the transanorectal total mesangectomy (TaTME) treatment of rectal cancer has an acceptable LR rate
.
Original source:
Original source:Sapho X.
Roodbeen, Marta Penna, MBBS, Susan van Dieren, et al.
Local Recurrence and Disease-Free Survival After Transanal Total Mesorectal Excision: Results From the International TaTME Registry.
J Natl Compr Canc Netw, doi: 10.
6004/jnccn.
2021.
7012 .
Published online August 17, 2021.
Roodbeen, Marta Penna, MBBS, Susan van Dieren, et al.
Local Recurrence and Disease-Free Survival After Transanal Total Mesorectal Excision: Results From the International TaTME Registry.
J Natl Compr Canc Netw, doi: 10.
6004/jnccn.
2021.
7012 .
Published online August 17, 2021.
Leave a message here
